Incidence due to lung canceraccounted for 20.3% of all male cancer cases.WORLD SCENARIOThe crude incidence rate was 22.8/10 5 .There is a great variation in the prevalence of Incidence due to lung cancer accounted forlung cancer in different geographical areas. 16.1% among all female cancer ...
Lung cancer is a condition where cells multiply in the lungs uncontrollably. This causes the development of tumours that decrease an individual's capacity to breathe. This development can spread beyond the lung by the process of metastasis into close-by tissue or different parts of the body. Ses...
Post-pulmonary embolism syndrome in patients with lung cancer: prevalence and clinical implications Post-pulmonary embolism (post-PE) syndrome, first introduced by Klok et al., refers to a clinical condition characterized by persistent, unexplained dyspnea, reduced physical activity, and impaired quality...
2023 & 2024 Lung Cancer Therapeutics market size report includes a forecast to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
With increasing prevalence of smoking, lung cancer has reached epidemic proportions in India. It has surpassed the earlier commonest form of cancer, that of oropharynx, and now is the commonest malignancy in males in many hospitals. In addition to smoking, occupational exposure to carcinogens, ...
For instance, Hengrui launched Sunitinib, an advanced targeted agent for lung cancer, while Jiangsu Hengrui’s Camrelizumab serves as an additional immune therapy. Such launches are much awaited in any country with lung cancer epidemic given the prevalence of smoking and environmental ozone. In ad...
Incidence due to lung canceraccounted for 20.3% of all male cancer cases.WORLD SCENARIOThe crude incidence rate was 22.8/10 5 .There is a great variation in the prevalence of Incidence due to lung cancer accounted forlung cancer in different geographical areas. 16.1% among all female cancer ...
Lung cancer is the most common cause of cancer and cancer death throughout the world. In the United States alone, lung cancer is expected to account for an estimated 169,400 of the 1.28 million new cases of cancer and 154,900 of 555,500 cancer deaths for
Somatic mutations together with immunoediting drive extensive heterogeneity within non-small-cell lung cancer (NSCLC). Herein we examine heterogeneity of the T cell antigen receptor (TCR) repertoire. The number of TCR sequences selectively expanded in tumors varies within and between tumors and correlat...
Tracheal metastasis of small cell lung cancer De Sajal Five-year trend of acquired antitubercular drug resistance in patients attending a tertiary care hospital at Dehradun (Uttarakhand) Rawat Jagdish,Sindhwani G,Dua Ruchi The impact of "World Health Organization - Government of India guidelines on...